Back to Journals » Therapeutics and Clinical Risk Management » Volume 16

Evaluating the Safety, Efficacy, and Therapeutic Potential of Momelotinib in the Treatment of Intermediate/High-Risk Myelofibrosis: Evidence to Date

Total article views   HTML views PDF downloads Totals
6,296 Dovepress* 5,314+ 735 6,049
PubMed Central* 982 249 1,231
Totals 6,296 984 7,280
*Since 25 September 2020
Total mentioned Facebook Delicious Reddit Twitter Others
29 0 0 0 1 28

View citations on PubMed and Google Scholar